Clinical and biological data on the use of hydroxychloroquine against SARS-CoV-2 could support the role of the NLRP3 inflammasome in the pathogenesis of respiratory disease

Authors :: Gerardo Musuraca
Paolo Silimbani
Paola Di Carlo
Mariasanta Napolitano
Giovanni Martinelli
Claudio Cerchione
Alessandro Lucchesi
Lucchesi, Alessandro
Silimbani, Paolo
Musuraca, Gerardo
Cerchione, Claudio
Martinelli, Giovanni
Di Carlo, Paola
Napolitano, Mariasanta
Source :: Journal of Medical Virology
Publication Year :: 2020
Abstract: The use of hydroxychloroquine (HCL) has been very common in countries with a rapid spread of coronavirus disease 2019 (COVID-19), although controversial and the subject of heated scientific discussions with implications for the whole society. This article is protected by copyright. All rights reserved.

Subjects :: 2019-20 coronavirus outbreak
Coronavirus disease 2019 (COVID-19)
business.industry
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Respiratory disease
Hydroxychloroquine
Inflammasome
medicine.disease
Virology
Pathogenesis
SARS-CoV-2, inlfammosome,hydroxycholoroquine
Infectious Diseases
Medicine
business
medicine.drug

Tools